Definitions and Outcome Measures of Clinical Trials Regarding Opioid-induced Constipation
Jan Gaertner(University Medical Center Freiburg), Gerhild Becker(University Medical Center Freiburg), Lynn R. Webster(Adherent Technologies (United States)), Michael Camilleri(CSIRO Manufacturing), Andrew Davies(GW Pharmaceuticals (United Kingdom)), Douglas A. Drossman(Rome Foundation), Waldemar Siemens(University Medical Center Freiburg)
Cited by 76
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886